Ticker

LYEL

Lyell Immunopharma, Inc.

5 catalysts on file

LYEL

Lyell Immunopharma, Inc.

Phase 2 AI-extracted

ronde-cel

large B-cell lymphoma (LBCL)

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 12h ago

Countdown card →

LYEL

Lyell Immunopharma, Inc.

Phase 1 AI-extracted

LYL273

metastatic colorectal cancer (mCRC)

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 12h ago

Countdown card →

LYEL

Lyell Immunopharma, Inc.

PDUFA AI-extracted

ronde-cel

large B-cell lymphoma (LBCL)

T-minus 178 days ~ Jan 1, 2027

SEC 8-K verified 12h ago

Countdown card →

LYEL

Lyell Immunopharma, Inc.

Phase 3 AI-extracted

ronde-cel

large B-cell lymphoma (LBCL)

T-minus 542 days ~ Dec 31, 2027

SEC 8-K verified 12h ago

Countdown card →

LYEL

Lyell Immunopharma, Inc.

PDUFA AI-extracted

LYL273

metastatic colorectal cancer (mCRC)

Date TBD Date TBD

SEC 8-K verified 12h ago

Countdown card →